Background: Therapeutic drug monitoring (TDM) is a decision-making tool for optimizing the
use of certain therapies. In this article, the authors review the role of proactive TDM of …

Introduction Therapeutic drug monitoring (TDM) is useful for optimizing monoclonal
antibodies (mAbs) for the treatment of immune-mediated inflammatory disorders including …

Abstract Background and Aims Adequate infliximab concentrations during induction
treatment are predictive for deep remission [corticosteroid-free clinical and endoscopic …

In the current era of treat-to-target strategies, therapeutic drug monitoring (TDM) has
emerged as a potential tool in optimizing the efficacy of biologics for children diagnosed with …

Introduction: Medical treatment of pediatric inflammatory bowel diseases (IBD) has been
greatly changed by the introduction of a number of biologic agents that are able to target …

Infliximab is commonly used in inflammatory bowel disease (IBD), however, differences in
clinical response among patients are common. Several studies have considered the …

Therapeutic drug monitoring (TDM) is a useful tool for optimising the use of anti-TNFα
inhibitors in patients with inflammatory bowel diseases (IBDs). Recently, point-of-care …

Background: The treatment for Crohn's disease (CD) has increasingly required the use of
biological agents. Safe and affordable tests have led to the active implementation of …

Infliximab and its anti-drug antibody (ADA) serum concentrations exhibit a strong correlation
with clinical response and loss of response. The use of therapeutic drug monitoring to …

The introduction of point-of-care (POC) assays into clinical practice in patients with
inflammatory disease enables on-demand therapeutic decision making. The aim of this …